Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization |
| |
| Authors: | Priyanka P Doctor Pooja Bhat Reema Sayed C Stephen Foster |
| |
| Institution: | Massachusetts Eye Research and Surgery Institute, Cambridge, Massachusetts, USA |
| |
| Abstract: | Purpose: To report 5 cases of inflammatory choroidal neovascularization (CNV) that were treated with intravitreal bevacizumab. Methods: Six eyes of 5 patients with uveitic CNV were treated with 2.5 mg/0.1 mL of intravitreal bevacizumab. Main outcome measures were the changes in BCVA and reduction in the size of the CNV. Results: The mean follow-up time was 15.3 months. The mean intravitreal injections administered were 2.7. All patients showed a reduction in the size of the CNV with improvement in BCVA in 60% of cases at the last follow-up. Conclusion: Intravitreal bevacizumab may provide an additional strategy in the management of inflammatory CNV. |
| |
| Keywords: | inflammatory choroidal neovascularization intravitreal bevacizumab uveitic CNV |
|
